Search

Your search keyword '"Tretyakova M"' showing total 194 results

Search Constraints

Start Over You searched for: Author "Tretyakova M" Remove constraint Author: "Tretyakova M"
194 results on '"Tretyakova M"'

Search Results

1. Female magnesium deficiency and its management: review of current knowledge

6. Coherent Dissociation $^{16}$O~$\rightarrow$~4$\alpha$ in Photoemulsion at an Incident Momentum of 4.5 GeV/$c$ per Nucleon

7. PB0094 Antiphospholipid Antibodies in Severe and Critically ill COVID-19 Patients

8. PB1442 Clinical Significance of PAI-I, F2 Thr165Met Genes Polymorphisms in Pregnant Women with a History of Thrombosis

9. PB0081 von Willebrand Factor and Myeloperoxidase as Laboratory Predictive Markers of In-Hospital Survival in Severe COVID-19 Patients

11. How to reduce a risk of venous thromboembolism while taking combined oral contraceptives

12. Study of the Radiosensitizing Action of Lithium Ascorbate Under Neutron and Photon Irradiation of Tumor Cells

13. Clinical significance of ADAMTS-13/vWF axis in pregnant women at different trimesters of gestation

14. Intrauterine activation of the fetal immune system in response to maternal COVID-19

15. Particle size and chemical composition of atmospheric precipitation in the snow cover of four settlements in the Republic of Buryatia.

16. Maurice Arthus

17. Clinical significance of assessing ADAMTS-13 and von Willebrand factor level in COVID-19 convalescent pregnant women

18. Functioning of the ADAMTS-13/vWF axis and its clinical significance

19. Antithrombotic therapy in COVID-19 patients

21. Prognostic value of von Willebrand factor in clinical practice

23. Preeclampsia and venous thromboembolism

24. Pathogenetic and prognostic significance of inflammation and altered ADAMTS-13/vWF axis in patients with severe COVID-19

26. Anticoagulants: dose control methods and inhibitors

27. Evaluation of influence of cytotoxic payload on biodistribution of HER2-targeting affibody-drug conjugates using a radioactive label

28. Metalloproteinases as biochemical markers of pregnancy pathology

29. Platelets, thrombo-inflammation and cancer

30. COVID-19 and thrombotic microangiopathy

31. Thrombotic storm, hemostasis disorders and thromboinflammation in COVID-19

32. Vaccine-induced immune thrombotic thrombocytopenia: definition, risks with different vaccines, and regulatory responses

33. Neutrophil extracellular traps: a role in inflammation and dysregulated hemostasis as well as in patients with COVID-19 and severe obstetric pathology

34. Features of nervous system damage in antiphospholipid syndrome

35. Novel coronavirus infection and Kawasaki disease.

37. Anticoagulant, anti-inflammatory, antiviral and antitumor properties of heparins

38. Macrophage activation syndrome in COVID-19

41. Thrombotic microangiopathy, DIC-syndrome and COVID-19: link with pregnancy prothrombotic state.

43. Clinical significance of measuring ADAMTS-13, its inhibitor and von Willebrand factor in obstetric and gynecological practice

45. Flow effects in high-energy nucleus collisions with Ag(Br) in emulsion

Catalog

Books, media, physical & digital resources